Maytansine CAS: 57103-68-1

CAS NO: 57103-68-1
Maytansine
Chemical Name: Maytansinol
Molecular Formula: C28H37ClN2O8
Formula Weight: 565.05
CAS No.: 57103-68-1
Description Review
Description

Maytansine is a type of chemotherapy medication used in the treatment of various types of cancer, including breast cancer and lung cancer. It belongs to the class of drugs called microtubule inhibitors, which prevent cancer cells from dividing and growing. Maytansine CAS: 57103-68-1 is the chemical compound that has been extensively studied for its effectiveness in treating cancer.

Chemical Name:

The chemical name for Maytansine is (3S,4R,5S,6R)-3-hydroxy-4,5-dimethoxy-6-methyl(7E,9E)-nona-7,9-dien-1-yl benzoate.

Molecular Formula:

The molecular formula of Maytansine is C34H47NO10.

Formula Weight:

The formula weight of Maytansine is 629.75 g/mol.

CAS No:

The CAS number for Maytansine is 57103-68-1.

Top Ten Keywords and Synonyms:

  1. Chemotherapy
  2. Microtubule inhibitor
  3. Breast cancer
  4. Lung cancer
  5. Antineoplastic agent
  6. Tumor growth
  7. DM1
  8. Antibody-drug conjugates
  9. Mitosis
  10. Vinca alkaloid

Other synonyms for Maytansine include Ansamitocin P-3, Emi 205, and NSC-153858.

Health Benefits:

Maytansine has been shown to be effective in the treatment of various types of cancer, particularly breast cancer and lung cancer. It works by disrupting the microtubules in cancer cells, preventing them from dividing and growing. Maytansine is often used in combination with other medications or as part of an antibody-drug conjugate to increase its effectiveness.

Potential Effects:

The potential effects of Maytansine include decreased tumor growth and replication. It works by binding to the microtubules in cancer cells and preventing them from functioning properly. This ultimately leads to the death of the cancer cells.

Product Mechanism:

Maytansine works by binding to the microtubules in cancer cells and preventing them from forming properly. Microtubules are essential for cell division, and when they are disrupted, cells cannot divide and grow. This leads to the death of cancer cells.

Safety:

Maytansine should only be used under the supervision of a qualified healthcare provider. It can cause serious side effects, including decreased production of blood cells, liver damage, and nerve damage. Patients who are allergic to Maytansine or any of its ingredients should not use this medication. It is important to tell your healthcare provider about all medications you are taking before starting treatment with Maytansine.

Side Effects:

Common side effects of Maytansine include fatigue, nausea, vomiting, diarrhea, fever, muscle pain, and weakness. Less common side effects may include decreased production of blood cells, liver damage, and nerve damage.

Dosing Information:

The dose of Maytansine will depend on the patient's age, weight, and overall health. The medication is usually given as an injection into the vein. Treatment may continue for several weeks or months.

Conclusion:

Maytansine is an effective chemotherapy medication used in the treatment of various types of cancer, particularly breast cancer and lung cancer. It works by disrupting the microtubules in cancer cells, preventing them from dividing and growing. While it can be effective in treating cancer, it can also cause serious side effects and should only be used under the supervision of a qualified healthcare provider.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us